From pioneer to expert: Dr CS Ho’s journey in the evolution of clinical mass spectrometry

Dr Chung Shun “CS” Ho, pioneer in mass spectrometry, gives an overview of how the technology and its associated tools have evolved from his 1995 debut. In this episode of Leaders in Conversation with Ronald Lo, General Manager of Roche Diagnostics Hong Kong, Dr Ho recounts how mass spectrometry started from a niche discipline to the evolved, integrated machinery it is today. When he first started at The Chinese University of Hong Kong, Dr Ho has been at the helm of working with mass spectrometry since its introduction to the university. Years of experimenting with it has led to discoveries in better testing techniques, analysis with upgraded accompanying software, and laboratory workflows. Improving skills in mass spectrometry is only one part of it, Dr Ho also enjoys that community of like-minded researchers and professionals he has encountered in this journey of clinical mass spectrometry.

Dr Chung Shun “CS” Ho, pioneer in mass spectrometry, gives an overview of how the technology and its associated tools have evolved from his 1995 debut. In this episode of Leaders in Conversation with Ronald Lo, General Manager of Roche Diagnostics Hong Kong, Dr Ho recounts how mass spectrometry started from a niche discipline to […]

From pioneer to expert: Dr CS Ho’s journey in the evolution of clinical mass spectrometry Read More »

Beyond the bite: why blood transfusion safety matters amidst the global dengue surge

dengue blood transfusion

Dengue cases have surged worldwide during the 2023-24 outbreak season, with the WHO reporting close to a historic high of over five million cases and more than 5000 dengue-related deaths in over 80 countries. [1] Dengue is capable of causing a transfusion-transmitted infection, with several case reports, including a case of severe dengue haemorrhagic fever.

Beyond the bite: why blood transfusion safety matters amidst the global dengue surge Read More »

Why early CSF testing is a game-changer for Alzheimer’s disease in China

Alzheimer’s disease in China

In this fourth issue of The Value of Diagnostics interview series, Professor Li Xia highlights the specialised role of the Geriatric Psychiatry Department at the Shanghai Mental Health Center in managing cognitive impairment. Unlike neurology departments that focus primarily on cerebrovascular or neurological causes, this department offers “whole-course management” encompassing cognitive function, emotional well-being, and

Why early CSF testing is a game-changer for Alzheimer’s disease in China Read More »

The value of rapid diagnostics: spotlighting POCT in Malaysia’s Poliklinik Ar Razi

poct, rapid poct, rapid diagnostics, point-of-care testing

Dr Ain and Dr Farhan, Principal Doctors at Poliklinik Ar Razi in Kuantan, Malaysia, discuss the transformative impact of Point-of-Care Testing (POCT) on their 24-hour primary care facility. Serving a community of approximately 2,000 patients monthly, the clinic manages a split of chronic non-communicable diseases – e.g. diabetes and hypertension – and acute communicable illnesses.

The value of rapid diagnostics: spotlighting POCT in Malaysia’s Poliklinik Ar Razi Read More »

The practical benefits of HCV antigen-antibody dual assay: Q&A with Prof Tawesak Tanwandee

hcv

Professor Tawesak Tanwandee, Professor of Gastroenterology at Mahidol University’s Siriraj Hospital, sits down to discuss how the HCV dual assay helps to streamline diagnosis and reduce patient dropout.  The HCV dual assay represents a significant shift from conventional screening by providing independent antigen and antibody results from a single test that delivers results in under

The practical benefits of HCV antigen-antibody dual assay: Q&A with Prof Tawesak Tanwandee Read More »

Co-creating change beyond the machine: why effective total lab automation starts with its people

total lab automation, change management, lab automation

In healthcare, the margin between life and death is measured by timely and precise clinical intervention. With diagnostics influencing the vast majority of clinical decisions [1], the laboratory serves as the definitive point of clarity – where clinical certainty calls, the lab answers.  To meet surging testing demands, labs are pivoting to total lab automation

Co-creating change beyond the machine: why effective total lab automation starts with its people Read More »

Why expanding access to accurate dengue tests is a critical need in Asia

Why expanding access to accurate dengue tests is a critical need in Asia thumbnail

The viral infection known as dengue is an increasing public health threat. In 2024, the World Health Organisation received reports of 14.6 million cases of this mosquito-borne virus – a historic high, with infections endemic in more than 100 countries [1]. That number is presumed to be a significant undercount; experts estimate that there are

Why expanding access to accurate dengue tests is a critical need in Asia Read More »

In Asia, divergent patient care journeys make dengue diagnosis a challenge

dengue diagnosis

Across the Asia Pacific region, the patient care journey for a dengue infection varies significantly depending on the structure of the local healthcare system [1]. The primary divide stems from whether care is delivered via a centralised model or a community-based model [1]. Delivering appropriate care for patients infected with the dengue virus is increasingly

In Asia, divergent patient care journeys make dengue diagnosis a challenge Read More »

AI – Người bạn đồng hành thiết yếu của giải phẫu bệnh kỹ thuật số hiện đại: Hỏi & Đáp cùng Bác sĩ Kunal Sharma

Bridging the quality gap in digital pathology from pre analytics to AI QA with Dr Kunal Sharma

Trong tập Đối thoại Lãnh đạo này, Tiến sĩ Rishubh Gupta, Tổng giám đốc Roche Diagnostics Ấn Độ sẽ trao đổi với Tiến sĩ Kunal Sharma, Phó Chủ tịch Agilent Diagnostics, về vai trò chuyển đổi của giải phẫu bệnh kỹ thuật số và trí tuệ nhân tạo trong ngành chăm sóc sức khỏe Ấn

AI – Người bạn đồng hành thiết yếu của giải phẫu bệnh kỹ thuật số hiện đại: Hỏi & Đáp cùng Bác sĩ Kunal Sharma Read More »

Định liều kỹ thuật số và tương lai của giám sát nồng độ thuốc trong điều trị: Những góc nhìn từ Hội nghị quốc tế IATDMCT lần thứ 23

therapeutic drug monitoring

Khi đề cập đến điều trị, thách thức lâm sàng cốt lõi thường được gói gọn trong một câu hỏi mang tính quyết định: liều lượng thuốc bao nhiêu là đủ, và thời gian điều trị nên kéo dài bao lâu? Trong suốt một thời gian dài, khát vọng hướng tới y học cá thể

Định liều kỹ thuật số và tương lai của giám sát nồng độ thuốc trong điều trị: Những góc nhìn từ Hội nghị quốc tế IATDMCT lần thứ 23 Read More »

Scroll to Top